Detection of HCV and HIV-1 antibody negative infections in Scottish and Northern Ireland blood donations by nucleic acid amplification testing

Vox Sanguinis

Volumn 89, Issue 3, 2005, Pages 128-134

  Jarvis, Lisa M ^a,e   Dow, B C ^b   Cleland, A ^a   Davidson, F ^a   Lycett, C ^a   Morris, K ^c   Webb, B ^c   Jordan, A ^d   Petrik, J ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b SCOTTISH NATIONAL BLOOD TRANSFUSION SERVICE   (United Kingdom)

^c BELFAST CITY HOSPITAL   (United Kingdom)

^d South East of Scotland Blood Transfusion Centre   (United Kingdom)

^e UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Cost benefit; HCV NAT; HIV NAT; NAT methodology; Window donation

Indexed keywords

BLOOD ANALYSIS; BLOOD DONOR; COST BENEFIT ANALYSIS; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; NUCLEIC ACID AMPLIFICATION; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SAFETY; SEROCONVERSION; TORQUE TENO VIRUS; UNITED KINGDOM; VIRUS DETECTION; VIRUS GENOME; VIRUS TRANSMISSION;

ADULT; BLOOD DONORS; BLOOD TRANSFUSION; COST-BENEFIT ANALYSIS; FEMALE; HEPATITIS C; HIV INFECTIONS; HIV SERONEGATIVITY; HUMANS; IRELAND; MALE; MIDDLE AGED; NUCLEIC ACID AMPLIFICATION TECHNIQUES; SCOTLAND; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS;

EID: 25144481346     PISSN: 00429007     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1423-0410.2005.00686.x     Document Type: Review

References (24)

1. Jarvis L, Cleland A, Simmonds P, Dow B, Munro M, Jordan A, Prowse C, Yap PL: Screening blood donations for hepatitis C virus by polymerase chain reaction. Vox Sang, 2000; 78:57-58
2. Jarvis LM, Simmonds P: Scottish experience with NAT. Transfus Med 2002; 12:259-264
3. Franklin IM, Dow BC, Soldan K, Davidson K, Yirrel D, Hambley H, McClelland M: HIV-positive blood donations: Changing times, new responses. Transfus Med 2005; 13:54-55
4. Cleland A, Nettleton P, Jarvis L, Simmonds P: Use of bovine viral diarrhoea virus as an internal control for amplification of hepatitis C virus. Vox Sang 1999; 76:170-174
5. Cleland A, Davis C, Adams N, Lycett C, Jarvis LM, Holmes H, Simmonds P: Development of multiplexed nucleic acid testing for human immunodeficiency virus type 1 and hepatitis C virus. Vox Sang 2001; 81:93-101
6. Saldanha J, Heath A, Lelie N, Pisani G, Nubling M, Yu M: Calibration of HCV working reagents for NAT assays against the HCV international standard. The Collaborative Study Group. Vox Sang 2000; 78:217-224
7. Davis C, Heath A, Best S, Hewlett I, Lelie N, Schuurman R, Holmes H: Calibration of HIV-1 working reagents for nucleic acid amplification techniques against the 1st International Standard for HIV-1 RNA. J Virol Meth 2003; 107:37-44
8. Mellor J, Holmes EC, Jarvis LM, Yap PL, Simmonds P: Investigation of the pattern of hepatitis C virus sequence diversity in different geographical regions: implications for virus classification. The International HCV Collaborative Study Group. J General Virol 1995; 76:2493-2507
9. Chan SW, McOmish F, Holmes EC, Dow B, Peutherer JF, Follett E, Yap PL, Simmonds P: Analysis of a new hepatitis C virus type and its phylogenetic relationship to existing variants. J General Virol 1992; 73:1131-1141
10. Dow BC, Munro H, Buchanan I, Ferguson K, Davidson F, Lycett C, Jarvis L, Cleland A, Petrik J, Lumley S, MacLean A: Acute hepatitis C virus seroconversion in a Scottish blood donor: HCV antigen is not comparable with HCV nucleic acid amplification technology screening. Vox Sang 2004; 86:15-20
11. Morris K, Webb B, Dow B, McClelland M, Jordan T, Jarvis L: First HIV 'window period' donation in a UK blood donor. Transfus Med 2005; 15:249-250
12. European Agency for the Evaluation of Medicinal Products: Committee for Proprietary Medicinal Products: The introduction of nucleic acid amplification technology (NAT) for the detection of hepatitis c virus RNA in plasma pools (CPMP/BWP/390/97), March 24, 1998, London. Available at: http://www.emea.eu.int/ pdfs/human/bwp/026995en.pdf (accessed 26 July 2005)
13. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ: The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study. N Engl J Med 1996; 334:1685-1690
14. Flanagan P, Snape T: Nucleic acid technology (NAT) testing and the transfusion service: a rationale for the implementation of minipool testing. Transfus Med 1998; 8:9-13
15. Soldan K, Barbara JA, Ramsay ME, Hall AJ: Estimation of the risk of hepatitis B virus, hepatitis C virus and human immunodeficiency virus infectious donations entering the blood supply in England, 1993-2001. Vox Sang 2003; 84:274-286
16. Stramer SL, Glynn SA, Kleinman SH, Strong DM, Sally C, Wright DJ, Dodd RY, Busch MP: Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing. N Engl J Med 2004; 351:760-768
17. Delwart EL, Kalmin ND, Jones TS, Ladd DJ, Foley B, Tobler LH, Tsui RC, Busch MP: First report of human immunodeficiency virus transmission via an RNA-screened blood donation. Vox Sang 2004; 86:171-177
18. Schuttler CG, Caspari G, Jursch CA, Willems WR, Gerlich WH, Schaefer S: Hepatitis C virus transmission by a blood donation negative in nucleic acid amplification tests for viral RNA. Lancet 2000; 355:41-42
19. McClelland B, Contreras M: Appropriateness and safety of blood transfusion. BMJ 2005; 330:104-105
20. Simmonds P, Kurtz J, Tedder RS: The UK blood transfusion service: over a (patent) barrel? Lancet 2002; 359:1713-1714
21. Dow BC: Surveillance of blood-borne infections in donated blood, Scotland 2003; HPS Weekly Report 2005; 39:2005/03:21-22
22. The UK Collaborative Group for HIV and STI Surveillance: Focus on Prevention. HIV and other Sexually Transmitted Infections in the United Kingdom in 2003. The HIV epidemic in the United Kingdom. Health Protection Agency Centre for Infections 2004: 10-23. Available at: http://www.hpa.org.uk/infections/ topics_az/hiv_and_sti/publications/annual2004/focusonprevention.pdf
23. Health Protection Scotland: Focus: HIV in Scotland Review, 2004. HPS Weekly Report 2005; 39:2005/03:18-19. Available at: http://www.show.scot.nhs.uk/ scieh/PDF/pdf2005/0503.pdf (accessed 26 July 2005)
24. Serious Hazards of Transfusion (SHOT) Steering Group: Summary of Annual Report 2003, 2004. Manchester, SHOT Office. Available at: http://www.shotuk.org (accessed 26 July 2005)